Ear Diseases (Disease, Ear)

Subscribe to Selected New Research on Ear Diseases

115 relevant articles (1 outcomes, 9 trials/studies) found for this Disease

Description: Pathological processes of the ear, the hearing, and the equilibrium system of the body.

Also Known As:

Disease, Ear; Diseases, Ear; Ear Disease; Otological Diseases; Disease, Otologic; Disease, Otological; Diseases, Otologic; Diseases, Otological; Otologic Disease; Otological Disease; Otologic Diseases

Relationship Network

Disease Context: Research Results

Otorhinolaryngologic Diseases: 123

Ear Diseases: 115

Otosclerosis: 745

Otitis: 563

Hearing Disorders: 179

Middle Ear Cholesteatoma: 152

Labyrinth Diseases: 123

Tympanic Membrane Perforation: 110

Earache: 96

Herpes Zoster Oticus: 28

Ear Neoplasms: 6

Acquired Ear Deformities: 1

Retrocochlear Diseases: 1

Related Diseases

1.	Otitis Media
2.	Hearing Loss (Hearing Impairment)
3.	Otosclerosis
4.	Cholesteatoma
5.	Histiocytosis

Experts

1.	Kitahara, Tadashi: 1 article (01/2007)
2.	Uno, Atsuhiko: 1 article (01/2007)
3.	Mitani, Kenji: 1 article (01/2007)
4.	Kizawa, Kaoru: 1 article (01/2007)
5.	Masumura, Chisako: 1 article (01/2007)
6.	Horii, Arata: 1 article (01/2007)
7.	Kubo, Takeshi: 1 article (01/2007)
8.	Román, Julio San: 1 article (06/2005)
9.	Vazquez, Blanca: 1 article (06/2005)
10.	Parra, Juan: 1 article (06/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Ear Diseases:

1.	Ciprofloxacin (Cipro)FDA LinkGeneric 05/01/1989 - "Ciprofloxacin has been shown to be effective in the management of chronic ear disease." 05/01/1989 - "To evaluate the role of ciprofloxacin in the treatment of chronic ear disease, 21 patients who failed routine therapy for chronic ear disease were prospectively treated with oral ciprofloxacin" 05/01/1989 - "Ciprofloxacin for the treatment of chronic ear disease." 12/01/1995 - "OBJECTIVE: To determine and compare the therapeutic efficiency of ciprofloxacin hydrochloride and gentamicin sulfate in the treatment of chronic ear disease" Order ALL the reference details at left...
2.	Collagen Type II (Type II Collagen)IBA 12/29/1997 - "Molecular basis of type II collagen autoimmune ear diseases." 01/01/1996 - "Type II collagen-induced autoimmune ear disease in mice: a preliminary report on an epitope of the type II collagen molecule that induced inner ear lesions." 03/01/1986 - "These findings do not support previously reported observations that type II collagen autoimmunity results in ear disease." 05/01/1985 - "In 1981, the authors described a type II collagen-induced autoimmune ear disease (CIAED) model" 07/01/2002 - "Autoimmune ear disease induced by type II collagen has been investigated by Yoo et al. In the present study, we investigated the effects of direct chronic infusion of type II collagen-specific monoclonal antibodies into guinea pig cochlea" Order ALL the reference details at left...
3.	Anti-Bacterial Agents (Antibiotics)IBA 09/01/1998 - "CONCLUSIONS: The use of prophylactic antibiotics in surgery for chronic ear disease cannot be recommended based on the findings of this study." 09/01/1998 - "The current study was designed to evaluate the role of prophylactic antibiotics in the outcomes of surgery for chronic ear disease" 01/01/2001 - "Since the advent of antibiotics, endocranial complications due to infectious ear disease are actually unfrequent" 06/01/2000 - "Use of ototopical antibiotics in treating 3 common ear diseases." 09/01/1998 - "Prophylactic antibiotics in surgery for chronic ear disease." Order ALL the reference details at left...
4.	Cyanogen BromideIBA 01/01/1996 - "To identify the epitope on the type II collagen molecule that induced autoimmune ear disease, electrophysiological and histological studies were carried out in DBA/1J mice immunized with native chick type II collagen (Clln) and cyanogen bromide (CNBr) peptide 1I (CB-I1 peptide) that was cleaved from chicken type II collagen with CNBr digestion" 07/01/2001 - "B10.RIII (H-2r) mice were orally administered cyanogen bromide peptide 11 (CB11) or cholera toxin B (CTB)-conjugated CB11 to induce tolerance in collagen-induced autoimmune ear disease" Order ALL the reference details at left...
5.	Thiethylperazine (Thiethylperazine Malate)FDA Link 09/15/1969 - "Clinical studies on the use of torecan in ear diseases]" Order ALL the reference details at left...
6.	NicergolineIBA 09/01/1979 - "Clinical study of injectable sermion in otologic diseases]" Order ALL the reference details at left...
7.	Monoclonal AntibodiesIBA 07/01/2002 - "Autoimmune ear disease induced by type II collagen has been investigated by Yoo et al. In the present study, we investigated the effects of direct chronic infusion of type II collagen-specific monoclonal antibodies into guinea pig cochlea" Order ALL the reference details at left...
8.	PlastiporeIBA 05/01/1999 - "STUDY DESIGN: A retrospective review of 237 patients who underwent operation for chronic ear disease as well as ossiculoplasty with plastipore prostheses" Order ALL the reference details at left...
9.	ifenprodilIBA 01/01/1974 - "Study of the action of Vadilex in the therapy of otologic diseases with vascular components]" Order ALL the reference details at left...
10.	CollagenIBA 05/01/1985 - "Factors influencing collagen-induced autoimmune ear disease." 01/01/1996 - "Because similar inner ear lesions were induced by immunization with Clln and CB-I1 peptide, CB-I1 peptide contains at least one epitope that induces autoimmune inner ear disease in collagen II-induced disease on the chick type II collagen molecule involved in pathogenesis of autoimmune ear disease" 08/01/1994 - "An immune response directed against type II collagen (CII) has been reported in several autoimmune diseases including the animal models of collagen-induced arthritis (CIA) and collagen-induced autoimmune ear disease (CIAED)" 07/01/2001 - "B10.RIII (H-2r) mice were orally administered cyanogen bromide peptide 11 (CB11) or cholera toxin B (CTB)-conjugated CB11 to induce tolerance in collagen-induced autoimmune ear disease" 07/01/2001 - "Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease." Order ALL the reference details at left...

Therapies and Procedures

1.	Prostheses and Implants (Prosthesis) 06/01/1999 - "CONCLUSIONS: The DCB represents an excellent alternative to biocompatible prostheses for ossicular reconstruction in the setting of severe chronic ear disease" 01/01/1999 - "The experience of the surgeon in otologic surgery, severity of the chronic ear disease, status of the eustachian tube, extention of the ossicular chain disruption, type of surgery and characteristics of the prosthesis are critical for ossiculoplasty." 01/01/2005 - "Of 54 ears had only adhering in middle ear but no had been radical or incorporate chlosteatoma who underwent operation from January 1999 to May 2003 for chronic ear disease as well as ossiculoplasty with multi-technique measures (for example auto-bone cup-pole or gung-pole as total and partial ossicular replacement prostheses; scute rebuild by auto-bone; absorbable Merogel; tympanic chorda nerve as a spring press prostheses etc) were used in operation, and were followed up mean (26.11 +/- 11.31) months (range 12 approximately 53 months)" 05/01/1999 - "STUDY DESIGN: A retrospective review of 237 patients who underwent operation for chronic ear disease as well as ossiculoplasty with plastipore prostheses" 01/01/2007 - "The efficiency of titanium middle ear prosthesis for ossicular reconstruction in chronic ear disease is investigated in a Scandinavian two-center retrospective study from a Norwegian tertiary otology referral center and a Finnish otology referral center" Order ALL the reference details at left...
2.	Hearing Aids (Hearing Aid) 06/01/2004 - "The purpose of this study was to evaluate the value and effectiveness of a direct referral hearing aid clinic (DRHAC) in providing appropriate hearing aids to young patients aged 18-60 years while at the same time identifying patients with significant ear disease who need an otologist's opinion" 04/01/1991 - "This is based on the assumption that very few patients referred for hearing aids have significant ear disease and it is not necessary for them to see an ENT specialist" 11/01/1967 - "The construction of hearing aids for ear diseases]" 11/01/1983 - "Inadvertent placement of molding for a hearing aid in the middle ear space caused symptoms of chronic ear disease, including pain, otorrhea, vertigo, and progressive neurosensory hearing loss" Order ALL the reference details at left...
3.	Adenoidectomy 08/01/1965 - "ADENOIDECTOMY: INDICATIONS AND TECHNIQUE IN OTOLOGIC DISEASE." 06/01/1997 - "PATIENTS AND METHODS: The study included 44 children with bilateral effusive otitis media and 32 children without ear disease, all of whom were scheduled for adenoidectomy" Order ALL the reference details at left...
4.	Tympanoplasty 03/01/2004 - "Development of persistent ipsilateral otological disease requiring a subsequent ipsilateral procedure was approximately twice as common in the tympanoplasty group" 09/01/1987 - "Poor eustachian tube function and prevalence of infectious ear disease are thought to be the reasons for less successful outcome associated with tympanoplasty in children" 08/01/1979 - "Mastoidectomy is required in more advanced chronic ear disease; if disease is not too extensive, hearing may be restored by tympanoplasty." 08/01/1978 - "Tympanoplasty is a surgical procedure that has been used in various modifications for the last 25 years for chronic ear disease" 04/01/1976 - "Ear disease in Western Canadian natives with a note on treatment by tympanoplasty." Order ALL the reference details at left...
5.	Middle Ear Ventilation (Tympanostomy) 04/01/2006 - "No difference could be seen between those who had had episodes of ear disease but no treatment with tympanostomy tubes and those who had had no documented ear disease" 04/01/2006 - "The prevalence of elevated thresholds in audiometric screening at conscription was compared for the group of boys who had been treated with tympanostomy tubes and the group of boys with no history of ear disease" 05/01/1988 - "Cleft type did not influence the degree of ear disease although more patients with complete clefts had a history of repeated grommet insertion" 11/01/1981 - "Appropriate use of tympanostomy tubes has significantly reduced the incidence of chronic ear disease" 11/01/2007 - "METHODS: Charts were reviewed to identify patients diagnosed with either a congenital syndrome or multiple major malformations with a known association with the development of chronic ear disease who underwent ear surgery for chronic ear disease (excluding tympanostomy tube placement)" Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Ear Diseases

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>